Anti-miRNA oligonucleotides: A comprehensive guide for design
- 4 March 2018
- journal article
- review article
- Published by Taylor & Francis in RNA Biology
- Vol. 15 (3) , 338-352
Abstract
MicroRNAs (miRNAs) are small, non-coding RNA molecules that regulate gene expression post-transcriptionally. As a consequence of their function towards mRNA, miRNAs are widely associated with the pathogenesis of several human diseases, making miRNAs a target for new therapeutic strategies based on the control of their expression. Indeed, numerous works were published in the past decades showing the potential use of antisense oligonucleotides to target aberrant miRNAs (AMOs) involved in several human pathologies. New classes of chemical-modified-AMOs, including locked nucleic acid oligonucleotides, have recently proved their worth in silencing miRNAs. A correct design of a specific AMOs can help to improve their performance and potency towards the target miRNA by increasing for instance nuclease resistance and target affinity. This review outlines the technologies involved to suppress aberrant miRNAs. From the design strategies used in AMOs to its application in novel miRNA-based therapeutics and detection methodologies.Keywords
Funding Information
- Laboratory for Process Engineering, Environment, Biotechnology and Energy (UID/EQU/00511/2013)
- Institute for Research and Innovation in Health Sciences (PEst-C/SAU/LA0003/2013)
- North Portugal Regional Operational Program (NORTE2020)
- FCT – Foundation for Science and Technology and Biomode 2 (SFRH/BDE/51909/2012)
This publication has 139 references indexed in Scilit:
- Improved Performance of Anti-miRNA Oligonucleotides Using a Novel Non-Nucleotide ModifierMolecular Therapy Nucleic Acids, 2013
- Silencing of microRNA families by seed-targeting tiny LNAsNature Genetics, 2011
- MiR‐9 downregulates CDX2 expression in gastric cancer cellsInternational Journal of Cancer, 2011
- Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probesMethods, 2010
- miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasisNature Cell Biology, 2010
- Silencing of microRNAs in vivo with ‘antagomirs’Nature, 2005
- TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencingNature, 2005
- MicroRNA expression profiles classify human cancersNature, 2005
- The Microprocessor complex mediates the genesis of microRNAsNature, 2004
- Processing of primary microRNAs by the Microprocessor complexNature, 2004